Entity
  • BILHI Genetics

    Created in 2012
  • BETA

    To investigate (B)
    Some signals may appear as inconsistent with a regular activity
  • Social networks

    200 643
  • Activities

  • Technologies

  • Entity types

  • Location

    19 Rue Roux de Brignoles, 13006 Marseille, France

    Marseille

    France

  • Employees

    Scale: 11-50

    Estimated: 4

  • Engaged corporates

    1
    1 1
  • Added in Motherbase

    4 years, 3 months ago
Description
  • Value proposition

    The genetic platform to EXPLORE, PREDICT and CURE fibrotic diseases


    We are a team of GENOMIC EXPLORERS dedicated to cure fibrosis. We work hand in hand with populations under strong natural selection pressure (e.g. Amerindians from Brazil, Allurs, Bantous from Uganda, Hans from Wuhan...) to identify GENETIC VARIANTS of susceptibility or resistance to fibrotic diseases.

    To explore the mechanisms of fibrosis in new depth, we rely on a unique genomic strategy based on medical genetic expertise in fibrosis, local networks of fields experts and state-of-the-art AI. In cooperation with local institutions & KOLs, our experts have analyzed tens of thousands of samples (plasma, blood, saliva, DNA and RNA, medical exams, exogenic factors) and led pioneering genetic research in the fields of infectious, parasitic & metabolic diseases.* Our goal is to build a unique dataset representative of humanity's diversity to bring disease prevention and cure to all communities.

    * We always collect samples and data hand in hand with local authorities and populations. We follow up on our patients and bring healthcare to the populations who need it the most by maintaining local teams and by coordinating with NGOs and local authorities.

    Personalized medicine, software, genomics, fibrosis, AI, and Drug Development

  • Original language

    The genetic platform to EXPLORE, PREDICT and CURE fibrotic diseases


    We are a team of GENOMIC EXPLORERS dedicated to cure fibrosis. We work hand in hand with populations under strong natural selection pressure (e.g. Amerindians from Brazil, Allurs, Bantous from Uganda, Hans from Wuhan...) to identify GENETIC VARIANTS of susceptibility or resistance to fibrotic diseases.

    To explore the mechanisms of fibrosis in new depth, we rely on a unique genomic strategy based on medical genetic expertise in fibrosis, local networks of fields experts and state-of-the-art AI. In cooperation with local institutions & KOLs, our experts have analyzed tens of thousands of samples (plasma, blood, saliva, DNA and RNA, medical exams, exogenic factors) and led pioneering genetic research in the fields of infectious, parasitic & metabolic diseases.* Our goal is to build a unique dataset representative of humanity's diversity to bring disease prevention and cure to all communities.

    * We always collect samples and data hand in hand with local authorities and populations. We follow up on our patients and bring healthcare to the populations who need it the most by maintaining local teams and by coordinating with NGOs and local authorities.

Corporate interactions BETA
Corporate TypeTweets Articles
NEFTYS
NEFTYS
Finance, Financial Services
NEFTYS
Finance, Financial Services
Other

25 Aug 2023


Similar entities
Loading...
Loading...
Social network dynamics